Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Description
Kebotix is a pioneering technology platform focused on the development of new chemicals and materials, heralding a transformative era of rapid innovation through the integration of artificial intelligence and robotic automation. The company has introduced the world's first autonomous laboratory dedicated to materials discovery, driven by AI and robotics, which revolutionizes traditional research methods. By greatly enhancing the exploration, discovery, utilization, and production of novel molecules and materials, Kebotix aims to address some of the most pressing challenges faced globally. Collaborate with us to expedite the market introduction of your products while leveraging our cutting-edge material design technologies that are enabled by our self-driving lab. Kebotix propels your research and development efforts into the new digital frontier by offering tailored enterprise AI solutions specifically designed for materials discovery. With our automated learning system that improves with each cycle of predict-produce-prove, we empower you to deliver superior products to market more swiftly than ever before. This innovative approach not only saves time but also significantly enhances the efficiency of the research process.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Atomwise
Founded
2012
Country
United States
Website
www.atomwise.com
Vendor Details
Company Name
Kebotix
Founded
2017
Country
United States
Website
www.kebotix.com